Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$52.03 USD

52.03
732,290

+0.17 (0.33%)

Updated Aug 16, 2024 04:00 PM ET

After-Market: $52.04 +0.01 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (149 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive

Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.

AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?

AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Why You Should Add Veeva Systems (VEEV) to Your Portfolio

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

HealthEquity (HQY) Q1 Earnings Beat Estimates, FY22 View Up

HealthEquity (HQY) delivers solid growth in HSAs along with recording robust Interchange revenues in the first quarter of fiscal 2022.

3 Reasons Growth Investors Will Love AMN Healthcare (AMN)

AMN Healthcare (AMN) could produce exceptional returns because of its solid growth attributes.

Here's Why AMN Healthcare Services (AMN) is a Great Momentum Stock to Buy

Does AMN Healthcare Services (AMN) have what it takes to be a top stock pick for momentum investors? Let's find out.

LHC Group (LHCG) Forays Into Oregon With New Acquisition

LHC Group (LHCG) acquires Home 'n Hospice to expand its existing footprint in Idaho.

AMN Healthcare (AMN) is an Incredible Growth Stock: 3 Reasons Why

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

PerkinElmer (PKI) Boosts Cell Biology Portfolio With Buyout

PerkinElmer (PKI) enters into an agreement to acquire Nexcelom that will enable the former to boost its efforts when it comes to solutions for drug discovery.

Earnings Estimates Rising for AMN Healthcare (AMN): Will It Gain?

AMN Healthcare (AMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

AMN Healthcare (AMN) Upgraded to Buy: What Does It Mean for the Stock?

AMN Healthcare (AMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?

AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates

AMN Healthcare (AMN) gains from segmental strength in the first quarter.

AMN Healthcare (AMN) Soars 5.6%: Is Further Upside Left in the Stock?

AMN Healthcare (AMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AMN Healthcare Services (AMN) Q1 Earnings and Revenues Top Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 25.00% and 9.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

AMN Healthcare Services (AMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services

The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services

4 Stocks That Continue to Gain From Telehealth Offerings

We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.

Why Is AMN Healthcare (AMN) Up 2.5% Since Last Earnings Report?

AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

Investor optimism is high on AMN Healthcare (AMN) stock, courtesy of its solid prospects.

Teladoc (TDOC) Q4 Loss Widens, Revenues Surpass Estimates

Teladoc's (TDOC) Q4 earnings result reflects revenue gains, more than offset by flared-up expenses.

AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates

AMN Healthcare (AMN) gains from the Nurse and Allied Solutions segment in the fourth quarter.

AMN Healthcare Services (AMN) Surpasses Q4 Earnings and Revenue Estimates

AMN Healthcare (AMN) delivered earnings and revenue surprises of 12.36% and 0.90%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Can AMN Healthcare (AMN) Keep the Earnings Surprise Streak Alive?

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.